COMPLICATIONS OF TRANSRECTAL ULTRASOUND-GUIDED 12-CORE PROSTATE BIOPSY- A 5-YEAR EXPERIENCE

Objective: The aim of our study was to estimate complication rates after 12-core TRUS-guided prostate biopsy for suspected carcinoma prostate following all recommended pre and post-procedural measures. Material and methods: This 5-year retrospective study included 69 patients, based on elevated serum PSA (≥4 ng/mL), abnormal digital rectal examination ndings and/or mpMRI ndings (PIRADS ≥3). All patients received prophylactic antibiotics and rectal enema prior to biopsy. Single-use disposable 18-G biopsy needle was used. Post-operative complications were recorded. Results: Minor complications were detected in 33.33%, including fever (1.45%), mild self-limiting hematuria (18.84%), rectal bleeding (4.35%) and urinary retention (20.75%). Serious complications which necessitated hospitalization occurred in 2 patients (2.89%) including urosepsis and hematuria with clot retention in the other. Conclusion: TRUS-guided prostate biopsy is safe for diagnosing prostate cancer with acceptable post-procedural complications when done taking all precautions.